Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway is a research paper published in Leukemia (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Medical University of South Carolina
Grant: SC SmartState Cancer Stem Cell Biology & Therapy Program
Medical University of South Carolina
Grant: DFG GRK2158
Medical University of South Carolina
Grant: SC SmartState Endowment in Lipidomics and Drug Discovery
U.S. Department of Health & Human Services | National Institutes of Health
Grant: AI118305
U.S. Department of Health & Human Services | National Institutes of Health
Grant: HL140953
U.S. Department of Health & Human Services | National Institutes of Health
Grant: CA214641
U.S. Department of Health & Human Services | National Institutes of Health
Grant: DE016572
U.S. Department of Health & Human Services | National Institutes of Health
Grant: P01 CA203628
National Institutes of Health
Grant: 5R01AI118305-05
MicroRNA Regulates Graft-versus-Host Disease
National Institutes of Health
Grant: 5R01HL140953-04
Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia Relapse
National Institutes of Health
Grant: 5R01DE016572-13
Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and Therapy
National Institutes of Health
Grant: 1P01CA203628-01
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
NIAID NIH HHS
Grant: R01 AI118305
NCI NIH HHS
Grant: R01 CA258440
NCI NIH HHS
Grant: R21 CA263140
NHLBI NIH HHS
Grant: R01 HL140953
NIDCR NIH HHS
Grant: R01 DE016572
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals